| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000014245 |
| Receipt No. | R000016594 |
| Official scientific title of the study | The exploratory study for the drug-predictive markers of TS-1 in metastatic or recurrent breast cancer; Translational biomarker study of SELECT BC trial |
| Date of disclosure of the study information | 2014/06/12 |
| Last modified on | 2018/10/12 (Ver. 8) |
| Basic information | ||
| Official scientific title of the study | The exploratory study for the drug-predictive markers of TS-1 in metastatic or recurrent breast cancer; Translational biomarker study of SELECT BC trial | |
| Title of the study (Brief title) | SELECT BC - the better drug predictive
marker analysis (SELECT BC-EURECA) |
|
| Region |
|
|
| Condition | |||
| Condition | Metastatic or recurrent breast cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To find the predictive biomarkers of TS-1 for the breast cancer based on expression of mRNA related with 5-FU metabolism using samples from patients who participated in SELECT BC trial |
| Basic objectives2 | Others |
| Basic objectives -Others | Transralational research for predictive biomarker of TS-1 |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Correlation between the bio-marker and clinical efficacy, i.e. PFS: progression free survival, of each patient who has participated in SELECT BC trial |
| Key secondary outcomes | Correlation between the bio-marker and clinical efficacy, i.e. TTF:Time to Treatment Failure, OS:Overall survival, and DCR:Disease control rate, of each patient who has participated in SELECT BC trial |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1) Institutional review board (IRB) approval for research and transportation of breast cancer samples
2) Availability to obtain surgical specimen or core needle biopsy sample of breast cancer |
|||
| Key exclusion criteria | 1) Patients not adequate for participation in this study at doctors' discretion.
2) Patients not obtained informed consentnot obtained informed consent |
|||
| Target sample size | 140 | |||
| Research contact person | |
| Name of lead principal investigator | Fumikata Hara |
| Organization | National Hospital Organization Shikoku Cancer Center |
| Division name | Department of breast oncology |
| Address | 160 Kou, Minamiumemoto-chou, Matsuyama |
| TEL | 089-999-1111 |
| hfumikat@shikoku-cc.go.jp | |
| Public contact | |
| Name of contact person | Akira Yamao |
| Organization | Public Health Research Foundation |
| Division name | Comprehensive Support Project for Oncology Research |
| Address | 1-1-7, Nishiwaseda, Shinjyuku-ku Tokyo, |
| TEL | 03-5287-2636 |
| Homepage URL | http://www.csp.or.jp/ |
| support@csp.or.jp | |
| Sponsor | |
| Institute | SELECT BC executive committee |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Public Health Research Foundation |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | None |
| Name of secondary funder(s) | None |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Not applicable |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016594 |